CLINICAL TRIALS PROFILE FOR INGENOL MEBUTATE
✉ Email this page to a colleague
All Clinical Trials for ingenol mebutate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00742391 ↗ | A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations | Completed | Peplin | Phase 3 | 2008-09-01 | The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses. |
| NCT00850681 ↗ | A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | Completed | Peplin | Phase 1 | 2009-02-01 | This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin. |
| NCT00850811 ↗ | A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | Completed | Peplin | Phase 1 | 2009-02-01 | This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure. |
| NCT00852137 ↗ | A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis | Completed | Peplin | Phase 2 | 2009-03-01 | This Phase II study is designed to evaluate the pharmacokinetics of PEP005 (ingenol mebutate) Gel, 0.05% when applied in a maximal use setting to the dorsal aspect of the forearm in patients with actinic keratoses |
| NCT00915551 ↗ | A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | Completed | Peplin | Phase 3 | 2009-06-01 | This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp. |
| NCT00916006 ↗ | A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | Completed | Peplin | Phase 3 | 2009-06-01 | This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp. |
| NCT00917306 ↗ | A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) | Completed | TKL Research, Inc. | Phase 3 | 2009-06-01 | The open label study is designed to assess the safety and efficacy of 0.05% PEP005 Gel when applied to an area of skin containing 4-8 AK lesions on non-head locations. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ingenol mebutate
Condition Name
Clinical Trial Locations for ingenol mebutate
Trials by Country
Clinical Trial Progress for ingenol mebutate
Clinical Trial Phase
Clinical Trial Sponsors for ingenol mebutate
Sponsor Name
